UK small-cap RNS · 12 Nov 2025
The key announcements of UK small & mid caps under £2bn on 12 Nov 2025 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 12 Nov | LendInvest LINV | £37m | Results | Results & Final Terms
LendInvest Secured Income III plc 8.25% Notes Due 2030: Announcement of Results and Final Terms Confirmation |
|
| 12 Nov | Ultimate Products ULTP | £38m | Results | Annual Report, AGM Notice & Proposed AIM Admission
Proposals for Cancellation of Ordinary Shares from the Official List, |
|
| 12 Nov | Ten Lifestyle Group TENG | £94m | Results | Final Results
Preliminary results for the year ended 31 August 2025 |
|
| 12 Nov | Acg Acquisition Company Limited Cls A ACG | £447m | Results | Results of Placing
ACG Metals Limited (LSE:ACG, ACGW) today announces the successful completion of its Placing announced on 11 November 2025. |
|
| 12 Nov | Arrow Exploration Corp. (Cdi) AXL | £106m | Results | Exploration Well M-5 Results
CALGARY, November 12, 2025 - Arrow Exploration Corp. |
|
| 12 Nov | Fuller Smith & Turner FSTA | £400m | Results | Half-year Results
Financial results for the 26 weeks to 27 September 2025 |
|
| 12 Nov | Motorpoint Group MOTR | £115m | Results | Half-year Results
Market outperformance leading to strong sales and profit growth, driven by investment in data and technology |
|
| 12 Nov | Volex VLX | £1,157m | Results | Half-year Results
Half year results for the period ended 30 September 2025 |
|
| 12 Nov | Avon Technologies plc AVON | £730m | Turnaround plan with targets | Final Results
o Addressable markets currently outpacing the previous 3-4.5% forecast annual growth rate |
|
| 12 Nov | Nuformix NFX | £2.9m | Results | Results of Underwritten Open Offer
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces the results of its underwritten Open Offer to Qualifying Shareholders which was announced on 28 October 2025 … |
|
| 12 Nov | Castings CGS | £120m | Results | Half-year Results
Revenue for the six months ended 30 September 2025 was £87.6 million (2024 - £89.2 million) with profit before tax increasing to £5.0 million (2024 - £4.1 million), in line with management expectations. |
|
| 12 Nov | London BTC Company Limited BTC | £5.2m | Results | Half-year Results
Interim results for the six-months ended 31 August 2025 |